Septerna (SEPN) Capital Expenditures (2023 - 2026)
Septerna's (SEPN) quarterly Capital Expenditures came in at $832000.0 in Q1 2026, up 117.8% year-on-year from $382000.0 in Q1 2025, and up 1180.0% quarter-over-quarter from $65000.0 in Q4 2025.
Septerna (SEPN) Capital Expenditures (2023 - 2026) Analysis & Trends
Septerna's Capital Expenditures history runs 4 years deep, the most recent figure standing at $832000.0 for Q1 2026.
- On a quarterly basis, Capital Expenditures rose 117.8% year-over-year to $832000.0 in Q1 2026; TTM through Mar 2026 was $968000.0, a 43.75% decrease from a year earlier, with the FY2025 full-year figure at $518000.0, down 75.37% from the prior year.
- Capital Expenditures climbed to $832000.0 in Q1 2026 per SEPN's latest filing, from $65000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $1.2 million in Q4 2023 and bottomed at $13000.0 in Q3 2025.
- The 4-year median for Capital Expenditures is $480000.0 (2024), against an average of $469200.0.
- Across the five-year window, Capital Expenditures slumped 97.75% in 2025 and surged 117.8% in 2026, its largest moves.
- Year by year, Capital Expenditures stood at $1.2 million in 2023, then sank by 50.61% to $612000.0 in 2024, then sank by 89.38% to $65000.0 in 2025, then soared by 1180.0% to $832000.0 in 2026.
- Per Business Quant, the three latest SEPN Capital Expenditures figures stand at $832000.0 (Q1 2026), $65000.0 (Q4 2025), and $13000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capital Expenditures (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -8,939.03 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 43.25 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 133.40 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 230.60 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 786,000.00 |
| 10 | Septerna | 1.50 Bn | 1.50 Bn | - | 832,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 832,000.00 |
| Mar 31, 2026 | 832,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Dec 31, 2025 | 65,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Sep 30, 2025 | 13,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Jun 30, 2025 | 58,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Mar 31, 2025 | 382,000.00 |
| Dec 31, 2024 | 612,000.00 |
| Dec 31, 2024 | 612,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Sep 30, 2024 | 578,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Jun 30, 2024 | 149,000.00 |
| Mar 31, 2024 | 764,000.00 |
| Mar 31, 2024 | 764,000.00 |
| Dec 31, 2023 | 1.24 Mn |
| Dec 31, 2023 | 1.24 Mn |